A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT03738397 · COMPLETED
Trial details
- NCT number
- NCT03738397
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-21
- Primary completion
- 2020-08-27
- Enrollment
- 673
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.